Skip to main content
Erschienen in: European Archives of Oto-Rhino-Laryngology 1/2015

01.01.2015 | Head and Neck

Clinical aspects of granulomatosis with polyangiitis affecting the head and neck

verfasst von: Andreas Knopf, Adam Chaker, Thomas Stark, Benedikt Hofauer, Tobias Lahmer, Klaus Thürmel, Murat Bas

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

There are many controversies in head and neck granulomatosis with polyangiitis (HN-GPA). Diagnostic/therapeutic regimens vary due to limited knowledge about the special properties of HN-GPA. 28 patients were diagnosed with GPA accordingly. Anti-neutrophil-cytoplasmatic-antibody (ANCA), anti-peroxidase-antibody (anti-PR3) and biopsies were performed for all patients and set into clinical context. 14 patients had sinonasal symptoms. Otological (n = 8) and laryngeal (n = 2) symptoms were usually associated with complex disease activity. Pulmonary and/or renal impairment was present in 14 patients at the time of diagnosis and developed in a further nine patients within 1 year. 21 patients with systemic disease displayed elevated ANCA/anti-PR3. In contrast, those with persistent isolated HN manifestations (n = 6) lacked auto-antibodies. These patients underwent multiple biopsies to diagnose GPA. Interestingly, five patients without clinical HN manifestations but elevated auto-antibodies were identified by nasal “blind” biopsy. Clinical examination, auto-antibody testing, and histology are effective diagnostic tools in HN-GPA. Histological diagnosis remains the gold standard in patients with persistent isolated head and neck manifestations but missing auto-antibodies. Based on our findings, we suggest early and sufficient systemic therapy for all HN-GPA. Nasal mucosal “blind” biopsy should be performed in patients with elevated auto-antibodies but lacking clinical head and neck manifestations.
Literatur
1.
Zurück zum Zitat Seo P, Stone JH (2004) The antineutrophil cytoplasmic antibody-associated vasculitides. Am J Med 117(1):39–50PubMedCrossRef Seo P, Stone JH (2004) The antineutrophil cytoplasmic antibody-associated vasculitides. Am J Med 117(1):39–50PubMedCrossRef
2.
Zurück zum Zitat McDonald TJ, DeRemee RA (1993) Head and neck involvement in Wegener’s granulomatosis (WG). Adv Exp Med Biol 336:309–313PubMedCrossRef McDonald TJ, DeRemee RA (1993) Head and neck involvement in Wegener’s granulomatosis (WG). Adv Exp Med Biol 336:309–313PubMedCrossRef
3.
Zurück zum Zitat Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL et al (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37(2):187–192PubMedCrossRef Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL et al (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37(2):187–192PubMedCrossRef
4.
Zurück zum Zitat Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD et al (1992) Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 116(6):488–498PubMedCrossRef Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD et al (1992) Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 116(6):488–498PubMedCrossRef
5.
Zurück zum Zitat Rasmussen N (2001) Management of the ear, nose, and throat manifestations of Wegener granulomatosis: an otorhinolaryngologist’s perspective. Curr Opin Rheumatol 13(1):3–11PubMedCrossRef Rasmussen N (2001) Management of the ear, nose, and throat manifestations of Wegener granulomatosis: an otorhinolaryngologist’s perspective. Curr Opin Rheumatol 13(1):3–11PubMedCrossRef
6.
Zurück zum Zitat Reinhold-Keller E, de Groot K (2010) Use of methotrexate in ANCA-associated vasculitides. Clin Exp Rheumatol 28(5 suppl 61):S178–S182PubMed Reinhold-Keller E, de Groot K (2010) Use of methotrexate in ANCA-associated vasculitides. Clin Exp Rheumatol 28(5 suppl 61):S178–S182PubMed
7.
Zurück zum Zitat Chen M, Kallenberg CG (2010) ANCA-associated vasculitides—advances in pathogenesis and treatment. Nat Rev Rheumatol 6(11):653–664PubMedCrossRef Chen M, Kallenberg CG (2010) ANCA-associated vasculitides—advances in pathogenesis and treatment. Nat Rev Rheumatol 6(11):653–664PubMedCrossRef
8.
Zurück zum Zitat Finkielman JD, Lee AS, Hummel AM, Viss MA, Jacob GL, Homburger HA et al (2007) ANCA are detectable in nearly all patients with active severe Wegener’s granulomatosis. Am J Med 120(7):643e9–643e14CrossRef Finkielman JD, Lee AS, Hummel AM, Viss MA, Jacob GL, Homburger HA et al (2007) ANCA are detectable in nearly all patients with active severe Wegener’s granulomatosis. Am J Med 120(7):643e9–643e14CrossRef
9.
Zurück zum Zitat Trimarchi M, Sinico RA, Teggi R, Bussi M, Specks U, Meroni PL (2013) Otorhinolaryngological manifestations in granulomatosis with polyangiitis (Wegener’s). Autoimmun Rev 12(4):501–505PubMedCrossRef Trimarchi M, Sinico RA, Teggi R, Bussi M, Specks U, Meroni PL (2013) Otorhinolaryngological manifestations in granulomatosis with polyangiitis (Wegener’s). Autoimmun Rev 12(4):501–505PubMedCrossRef
10.
Zurück zum Zitat Cannady SB, Batra PS, Koening C, Lorenz RR, Citardi MJ, Langford C et al (2009) Sinonasal Wegener granulomatosis: a single-institution experience with 120 cases. Laryngoscope 119(4):757–761PubMedCrossRef Cannady SB, Batra PS, Koening C, Lorenz RR, Citardi MJ, Langford C et al (2009) Sinonasal Wegener granulomatosis: a single-institution experience with 120 cases. Laryngoscope 119(4):757–761PubMedCrossRef
11.
Zurück zum Zitat Del Pero MM, Chaudhry A, Rasmussen N, Jani P, Jayne D (2013) A disease activity score for ENT involvement in granulomatosis with polyangiitis (Wegener’s). Laryngoscope 123(3):622–628PubMedCrossRef Del Pero MM, Chaudhry A, Rasmussen N, Jani P, Jayne D (2013) A disease activity score for ENT involvement in granulomatosis with polyangiitis (Wegener’s). Laryngoscope 123(3):622–628PubMedCrossRef
12.
Zurück zum Zitat Knopf A, Bas M, Chaker A, Strassen U, Pickhard A, Stark T et al (2011) Rheumatic disorders affecting the head and neck: underestimated diseases. Rheumatology (Oxford) 50(11):2029–2034CrossRef Knopf A, Bas M, Chaker A, Strassen U, Pickhard A, Stark T et al (2011) Rheumatic disorders affecting the head and neck: underestimated diseases. Rheumatology (Oxford) 50(11):2029–2034CrossRef
13.
Zurück zum Zitat Raynaud P, Garrel R, Rigau V, Poizat F, Vic P, Cartier C et al (2005) How can the diagnostic value of head and neck biopsies be increased in Wegener’s granulomatosis: a clinicopathologic study of 49 biopsies in 21 patients. Ann Pathol 25(2):87–93PubMedCrossRef Raynaud P, Garrel R, Rigau V, Poizat F, Vic P, Cartier C et al (2005) How can the diagnostic value of head and neck biopsies be increased in Wegener’s granulomatosis: a clinicopathologic study of 49 biopsies in 21 patients. Ann Pathol 25(2):87–93PubMedCrossRef
14.
Zurück zum Zitat Lee YT, Chang YS, Lai CC, Chen WS, Yang AH, Tsai CY (2012) Natural killer (NK)/T-cell lymphoma mimicking granulomatosis with polyangiitis (Wegener’s). Scand J Rheumatol 41(5):407–408PubMedCrossRef Lee YT, Chang YS, Lai CC, Chen WS, Yang AH, Tsai CY (2012) Natural killer (NK)/T-cell lymphoma mimicking granulomatosis with polyangiitis (Wegener’s). Scand J Rheumatol 41(5):407–408PubMedCrossRef
15.
Zurück zum Zitat Sokolowska-Wojdylo M, Florek A, Baranska-Rybak W, Sikorska M, Starzynska A, Drogoszewska B et al (2013) Natural killer/T-cell lymphoma, nasal type, masquerading as recalcitrant periodontitis in a patient with a diagnosis of Wegener’s granulomatosis. Am J Med Sci 345(2):163–167PubMedCrossRef Sokolowska-Wojdylo M, Florek A, Baranska-Rybak W, Sikorska M, Starzynska A, Drogoszewska B et al (2013) Natural killer/T-cell lymphoma, nasal type, masquerading as recalcitrant periodontitis in a patient with a diagnosis of Wegener’s granulomatosis. Am J Med Sci 345(2):163–167PubMedCrossRef
16.
Zurück zum Zitat Trimarchi M, Bussi M, Sinico RA, Meroni P, Specks U (2013) Cocaine-induced midline destructive lesions—an autoimmune disease? Autoimmun Rev 12(4):496–500PubMedCrossRef Trimarchi M, Bussi M, Sinico RA, Meroni P, Specks U (2013) Cocaine-induced midline destructive lesions—an autoimmune disease? Autoimmun Rev 12(4):496–500PubMedCrossRef
17.
Zurück zum Zitat Morales-Angulo C, Garcia-Zornoza R, Obeso-Aguera S, Calvo-Alen J, Gonzalez-Gay MA (2012) Ear, nose and throat manifestations of Wegener’s granulomatosis (granulomatosis with polyangiitis). Acta Otorrinolaringol Esp 63(3):206–211PubMedCrossRef Morales-Angulo C, Garcia-Zornoza R, Obeso-Aguera S, Calvo-Alen J, Gonzalez-Gay MA (2012) Ear, nose and throat manifestations of Wegener’s granulomatosis (granulomatosis with polyangiitis). Acta Otorrinolaringol Esp 63(3):206–211PubMedCrossRef
18.
Zurück zum Zitat Garske U, Haack A, Beltran O, Flores-Suarez LF, Bremer JP, Lamprecht P et al (2012) Intra- and inter-rater reliability of endonasal activity estimation in granulomatosis with polyangiitis (Wegener s). Clin Exp Rheumatol 30(1 Suppl 70):S22–S28PubMed Garske U, Haack A, Beltran O, Flores-Suarez LF, Bremer JP, Lamprecht P et al (2012) Intra- and inter-rater reliability of endonasal activity estimation in granulomatosis with polyangiitis (Wegener s). Clin Exp Rheumatol 30(1 Suppl 70):S22–S28PubMed
19.
Zurück zum Zitat Sepehr A, Alexander AJ, Chauhan N, Gantous A (2011) Detailed analysis of graft techniques for nasal reconstruction following Wegener granulomatosis. J Otolaryngol Head Neck Surg 40(6):473–480PubMed Sepehr A, Alexander AJ, Chauhan N, Gantous A (2011) Detailed analysis of graft techniques for nasal reconstruction following Wegener granulomatosis. J Otolaryngol Head Neck Surg 40(6):473–480PubMed
20.
Zurück zum Zitat Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP et al (1990) The American College of Rheumatology 1990 criteria for the classification of Wegener’s granulomatosis. Arthritis Rheum 33(8):1101–1107PubMedCrossRef Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP et al (1990) The American College of Rheumatology 1990 criteria for the classification of Wegener’s granulomatosis. Arthritis Rheum 33(8):1101–1107PubMedCrossRef
21.
Zurück zum Zitat Harabuchi Y, Kishibe K, Komabayashi Y (2013) Clinical manifestations of granulomatosis with polyangiitis (Wegener’s granulomatosis) in the upper respiratory tract seen by otolaryngologists in Japan. Clin Exp Nephrol 17(5):663–666 Harabuchi Y, Kishibe K, Komabayashi Y (2013) Clinical manifestations of granulomatosis with polyangiitis (Wegener’s granulomatosis) in the upper respiratory tract seen by otolaryngologists in Japan. Clin Exp Nephrol 17(5):663–666
22.
Zurück zum Zitat Alam DS, Seth R, Sindwani R, Woodson EA, Rajasekaran K (2012) Upper airway manifestations of granulomatosis with polyangiitis. Cleve Clin J Med 79(Suppl 3):S16–S21PubMedCrossRef Alam DS, Seth R, Sindwani R, Woodson EA, Rajasekaran K (2012) Upper airway manifestations of granulomatosis with polyangiitis. Cleve Clin J Med 79(Suppl 3):S16–S21PubMedCrossRef
23.
Zurück zum Zitat Popa ER, Tervaert JW (2003) The relation between Staphylococcus aureus and Wegener’s granulomatosis: current knowledge and future directions. Intern Med 42(9):771–780PubMedCrossRef Popa ER, Tervaert JW (2003) The relation between Staphylococcus aureus and Wegener’s granulomatosis: current knowledge and future directions. Intern Med 42(9):771–780PubMedCrossRef
24.
Zurück zum Zitat Malm IJ, Mener DJ, Kim J, Seo P, Kim YJ (2014) Otolaryngological progression of granulomatosis with polyangiitis after systemic treatment with rituximab. Otolaryngol Head Neck Surg 150(1):68–72PubMedCrossRef Malm IJ, Mener DJ, Kim J, Seo P, Kim YJ (2014) Otolaryngological progression of granulomatosis with polyangiitis after systemic treatment with rituximab. Otolaryngol Head Neck Surg 150(1):68–72PubMedCrossRef
25.
Zurück zum Zitat Charles P, Neel A, Tieulie N, Hot A, Pugnet G, Decaux O et al (2013) Rituximab for induction and maintenance treatment of ANCA-associated vasculitides: a multicentre retrospective study on 80 patients. Rheumatology (Oxford) 53(3):532–539 Charles P, Neel A, Tieulie N, Hot A, Pugnet G, Decaux O et al (2013) Rituximab for induction and maintenance treatment of ANCA-associated vasculitides: a multicentre retrospective study on 80 patients. Rheumatology (Oxford) 53(3):532–539
26.
Zurück zum Zitat Lally L, Lebovics R, Huang WT, Spiera RF (2014) A3.32 Efficacy of rituximab for the otolaryngologic manifestations of granulomatosis with polyangiitis. Ann Rheum Dis 73(Suppl 1):A55 Lally L, Lebovics R, Huang WT, Spiera RF (2014) A3.32 Efficacy of rituximab for the otolaryngologic manifestations of granulomatosis with polyangiitis. Ann Rheum Dis 73(Suppl 1):A55
27.
Zurück zum Zitat Taylor SC, Clayburgh DR, Rosenbaum JT, Schindler JS (2012) Progression and management of Wegener’s granulomatosis in the head and neck. Laryngoscope 122(8):1695–1700PubMedCrossRef Taylor SC, Clayburgh DR, Rosenbaum JT, Schindler JS (2012) Progression and management of Wegener’s granulomatosis in the head and neck. Laryngoscope 122(8):1695–1700PubMedCrossRef
28.
Zurück zum Zitat Kornblut AD, Wolff SM, Fauci AS (1982) Ear disease in patients with Wegener’s granulomatosis. Laryngoscope 92(7 Pt 1):713–717PubMedCrossRef Kornblut AD, Wolff SM, Fauci AS (1982) Ear disease in patients with Wegener’s granulomatosis. Laryngoscope 92(7 Pt 1):713–717PubMedCrossRef
29.
Zurück zum Zitat Stone JH (2003) Limited versus severe Wegener’s granulomatosis: baseline data on patients in the Wegener’s granulomatosis etanercept trial. Arthritis Rheum 48(8):2299–2309PubMedCrossRef Stone JH (2003) Limited versus severe Wegener’s granulomatosis: baseline data on patients in the Wegener’s granulomatosis etanercept trial. Arthritis Rheum 48(8):2299–2309PubMedCrossRef
30.
Zurück zum Zitat Bakthavachalam S, Driver MS, Cox C, Spiegel JH, Grundfast KM, Merkel PA (2004) Hearing loss in Wegener’s granulomatosis. Otol Neurotol 25(5):833–837PubMedCrossRef Bakthavachalam S, Driver MS, Cox C, Spiegel JH, Grundfast KM, Merkel PA (2004) Hearing loss in Wegener’s granulomatosis. Otol Neurotol 25(5):833–837PubMedCrossRef
31.
Zurück zum Zitat Gluth MB, Shinners PA, Kasperbauer JL (2003) Subglottic stenosis associated with Wegener’s granulomatosis. Laryngoscope 113(8):1304–1307PubMedCrossRef Gluth MB, Shinners PA, Kasperbauer JL (2003) Subglottic stenosis associated with Wegener’s granulomatosis. Laryngoscope 113(8):1304–1307PubMedCrossRef
32.
Zurück zum Zitat Taylor SC, Clayburgh DR, Rosenbaum JT, Schindler JS (2013) Clinical manifestations and treatment of idiopathic and Wegener granulomatosis-associated subglottic stenosis. JAMA Otolaryngol Head Neck Surg 139(1):76–81PubMedCrossRef Taylor SC, Clayburgh DR, Rosenbaum JT, Schindler JS (2013) Clinical manifestations and treatment of idiopathic and Wegener granulomatosis-associated subglottic stenosis. JAMA Otolaryngol Head Neck Surg 139(1):76–81PubMedCrossRef
33.
Zurück zum Zitat Wolter NE, Ooi EH, Witterick IJ (2010) Intralesional corticosteroid injection and dilatation provides effective management of subglottic stenosis in Wegener’s granulomatosis. Laryngoscope 120(12):2452–2455PubMedCrossRef Wolter NE, Ooi EH, Witterick IJ (2010) Intralesional corticosteroid injection and dilatation provides effective management of subglottic stenosis in Wegener’s granulomatosis. Laryngoscope 120(12):2452–2455PubMedCrossRef
34.
Zurück zum Zitat Tomasson G, Grayson PC, Mahr AD, Lavalley M, Merkel PA (2012) Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis–a meta-analysis. Rheumatology (Oxford) 51(1):100–109CrossRef Tomasson G, Grayson PC, Mahr AD, Lavalley M, Merkel PA (2012) Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis–a meta-analysis. Rheumatology (Oxford) 51(1):100–109CrossRef
Metadaten
Titel
Clinical aspects of granulomatosis with polyangiitis affecting the head and neck
verfasst von
Andreas Knopf
Adam Chaker
Thomas Stark
Benedikt Hofauer
Tobias Lahmer
Klaus Thürmel
Murat Bas
Publikationsdatum
01.01.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Oto-Rhino-Laryngology / Ausgabe 1/2015
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-014-2973-y

Weitere Artikel der Ausgabe 1/2015

European Archives of Oto-Rhino-Laryngology 1/2015 Zur Ausgabe

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Eingreifen von Umstehenden rettet vor Erstickungstod

15.05.2024 Fremdkörperaspiration Nachrichten

Wer sich an einem Essensrest verschluckt und um Luft ringt, benötigt vor allem rasche Hilfe. Dass Umstehende nur in jedem zweiten Erstickungsnotfall bereit waren, diese zu leisten, ist das ernüchternde Ergebnis einer Beobachtungsstudie aus Japan. Doch es gibt auch eine gute Nachricht.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.